Ireland is the latest country impacted by the rise in high-potency MDMA in the European market, with the HSE issuing a statement confirming that small pills can inflict significant damage when taken. Prof Eamon Keenan, HSE national clinical lead for addiction services, outlines the risks and symptoms of usage with Anton.
